Vasomune Therapeutics

Vasomune Therapeutics is a private biotechnology company dedicated to developing therapies for diseases associated with vascular dysfunction and instability. The innermost layer of blood vessels consists of a single layer of endothelial cells, which regulate the passage of immune and inflammatory cells to the site of injury. In many different disease states, vascular dysfunction leads to an excessive inflammatory response. Vascular dysfunction can cause or exacerbate many different diseases, such as those in the cardiovascular, renal, pulmonary, and oncology fields. The company's lead compound is Vasculotide, a Tie2 receptor agonist that has demonstrated positive therapeutic effects in many different diseases related to vascular dysfunction.